Sign inJoin waitlistJoin the waitlist

Alla Keyzner

Medical Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · · ·

History

Research

Sry-negative XX sex reversal in purebred dogs
Molecular Reproduction and Development · 1999 · Last of 5 authors · 60 citations
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
Review · The Lancet Haematology · 2020 · 54 citations
Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options
Review · Transfusion · 2015 · Last of 4 authors · 48 citations

John Mascarenhas
10 papers
Marina Kremyanskaya
7 papers
Uroosa Ibrahim
7 papers
Douglas Tremblay
6 papers
Jonathan Feld
5 papers
Alan Shih
4 papers
Lewis Silverman
4 papers
Aaron Gerds
3 papers
AB
Asad Bashey
3 papers
Bridget Marcellino
3 papers
Hany Elmariah
3 papers
Madiha Iqbal
3 papers

Clinical trials

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Principal investigator · Completed · Phase 1
Alla Keyzner
2019–2021
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Site PI · Recruiting · Phase 3
TScan Therapeutics, Inc.
2026–2029
A Long Term Follow-up Study of TScan TCR-T Products
Site PI · Recruiting
TScan Therapeutics, Inc.
2025–2040
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Site PI · Recruiting · Phase 1
TScan Therapeutics, Inc.
2022–2028